 |
|
|
| |
Transcriptional analysis of HBV infected liver after treatment with Selgantolimod reveals longitudinal changes in both inflammation-related pathways and B cell receptor repertoire
|
| |
| |
EASL 2023 June 21-24 Vienna
Nikita S. Kolhatkar1, Circe McDonald1, Samuel C. Kim1, Leonard Sowah1, Jeffrey J. Wallin1, Wan-Long Chuang2 and Yao-Chun Hsu3
1Gilead Sciences, Inc., Foster City, CA, USA; 2Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 3Center for Liver Diseases, E-Da Hospital, Kaohsiung 824, Taiwan
|
| |
|
|
|
|
|
